{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:25:00Z","timestamp":1793863500462,"version":"4.6.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["AA\/18\/1\/34219"],"award-info":[{"award-number":["AA\/18\/1\/34219"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/18\/6\/34217"],"award-info":[{"award-number":["RE\/18\/6\/34217"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Bristol Academic Career Development Fund"},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["218495\/Z\/19\/Z"],"award-info":[{"award-number":["218495\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT 217065\/Z\/19\/Z"],"award-info":[{"award-number":["WT 217065\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["202802\/Z\/16\/Z"],"award-info":[{"award-number":["202802\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["17\/0005645"],"award-info":[{"award-number":["17\/0005645"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Bristol NIHR Biomedical Research Centre","award":["BRC-1215-2001"],"award-info":[{"award-number":["BRC-1215-2001"]}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C18281\/A29019"],"award-info":[{"award-number":["C18281\/A29019"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health and Care Research (NIHR) Health Technology Assessment Programme","award":["HTA 09\/127\/53"],"award-info":[{"award-number":["HTA 09\/127\/53"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thousands of proteins circulate in the bloodstream; identifying those which associate with weight and intervention-induced weight loss may help explain mechanisms of diseases associated with adiposity. We aimed to identify consistent protein signatures of weight loss across independent studies capturing changes in body mass index (BMI). We analysed proteomic data from studies implementing caloric restriction (Diabetes Remission Clinical trial) and bariatric surgery (By-Band-Sleeve), using SomaLogic and Olink Explore1536 technologies, respectively. Linear mixed models were used to estimate the effect of the interventions on circulating proteins. Twenty-three proteins were altered in a consistent direction after both bariatric surgery and caloric restriction, suggesting that these proteins are modulated by weight change, independent of intervention type. We also integrated Mendelian randomisation (MR) estimates of the effect of BMI on proteins measured by SomaLogic from a UK blood donor cohort as a third line of causal evidence. These MR estimates provided further corroborative evidence for a role of BMI in regulating the levels of six proteins including alcohol dehydrogenase-4, nogo receptor and interleukin-1 receptor antagonist protein. These results indicate the importance of triangulation in interrogating causal relationships; further study into the role of proteins modulated by weight in disease is now warranted.<\/jats:p>","DOI":"10.1038\/s41598-023-47030-x","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T18:02:57Z","timestamp":1701280977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Using trials of caloric restriction and bariatric surgery to explore the effects of body mass index on the circulating proteome"],"prefix":"10.1038","volume":"13","author":[{"given":"Lucy J.","family":"Goudswaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"McConnachie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Blazeby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris A.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Suhre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaza B.","family":"Zaghlool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Hers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Timpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Corbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"47030_CR1","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41591-019-0665-2","volume":"25","author":"SA Williams","year":"2019","unstructured":"Williams, S. A. et al. Plasma protein patterns as comprehensive indicators of health. Nat. Med. 25, 1851\u20131857. https:\/\/doi.org\/10.1038\/s41591-019-0665-2 (2019).","journal-title":"Nat. Med."},{"key":"47030_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ijo.2010.137","volume":"35","author":"NJ Timpson","year":"2011","unstructured":"Timpson, N. J. et al. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int. J. Obes. (Lond.) 35, 300\u2013308. https:\/\/doi.org\/10.1038\/ijo.2010.137 (2011).","journal-title":"Int. J. Obes. (Lond.)"},{"key":"47030_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1559-0275-10-13","volume":"10","author":"AK F\u00fcz\u00e9ry","year":"2013","unstructured":"F\u00fcz\u00e9ry, A. K., Levin, J., Chan, M. M. & Chan, D. W. Translation of proteomic biomarkers into FDA approved cancer diagnostics: Issues and challenges. Clin. Proteom. 10, 13. https:\/\/doi.org\/10.1186\/1559-0275-10-13 (2013).","journal-title":"Clin. Proteom."},{"key":"47030_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/bmjebm-2020-111536","volume":"26","author":"P Malik","year":"2021","unstructured":"Malik, P. et al. Biomarkers and outcomes of COVID-19 hospitalisations: Systematic review and meta-analysis. BMJ Evid. Based Med. 26, 107\u2013108. https:\/\/doi.org\/10.1136\/bmjebm-2020-111536 (2021).","journal-title":"BMJ Evid. Based Med."},{"key":"47030_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","volume":"3","author":"SS Khan","year":"2018","unstructured":"Khan, S. S. et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 3, 280\u2013287. https:\/\/doi.org\/10.1001\/jamacardio.2018.0022 (2018).","journal-title":"JAMA Cardiol."},{"key":"47030_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/dom.12124","volume":"16","author":"SK Garg","year":"2014","unstructured":"Garg, S. K., Maurer, H., Reed, K. & Selagamsetty, R. Diabetes and cancer: Two diseases with obesity as a common risk factor. Diabetes Obes. Metab. 16, 97\u2013110. https:\/\/doi.org\/10.1111\/dom.12124 (2014).","journal-title":"Diabetes Obes. Metab."},{"key":"47030_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1071\/AH020207","volume":"25","author":"M Kortt","year":"2002","unstructured":"Kortt, M. & Baldry, J. The association between musculoskeletal disorders and obesity. Aust. Health Rev. 25, 207\u2013214 (2002).","journal-title":"Aust. Health Rev."},{"key":"47030_CR8","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/ije\/dyw314","volume":"45","author":"DA Lawlor","year":"2016","unstructured":"Lawlor, D. A., Tilling, K. & Davey Smith, G. Triangulation in aetiological epidemiology. Int. J. Epidemiol. 45, 1866\u20131886. https:\/\/doi.org\/10.1093\/ije\/dyw314 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"47030_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5934","volume":"347","author":"VL Gloy","year":"2013","unstructured":"Gloy, V. L. et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 347, f5934. https:\/\/doi.org\/10.1136\/bmj.f5934 (2013).","journal-title":"BMJ"},{"key":"47030_CR10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1552\/msb.20167357","volume":"12","author":"PE Geyer","year":"2016","unstructured":"Geyer, P. E. et al. Proteomics reveals the effects of sustained weight loss on the human plasma proteome. Mol. Syst. Biol. 12, 901. https:\/\/doi.org\/10.1552\/msb.20167357 (2016).","journal-title":"Mol. Syst. Biol."},{"key":"47030_CR11","doi-asserted-by":"publisher","first-page":"7913","DOI":"10.1038\/s41598-020-64636-7","volume":"10","author":"SM Figarska","year":"2020","unstructured":"Figarska, S. M. et al. Proteomic profiles before and during weight loss: Results from randomized trial of dietary intervention. Sci. Rep. 10, 7913. https:\/\/doi.org\/10.1038\/s41598-020-64636-7 (2020).","journal-title":"Sci. Rep."},{"key":"47030_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/prca.201600150","volume":"12","author":"S Oller Moreno","year":"2018","unstructured":"Oller Moreno, S. et al. The differential plasma proteome of obese and overweight individuals undergoing a nutritional weight loss and maintenance intervention. Proteom. Clin. Appl. 12, 1. https:\/\/doi.org\/10.1002\/prca.201600150 (2018).","journal-title":"Proteom. Clin. Appl."},{"key":"47030_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cels.2017.12.013","volume":"6","author":"BD Piening","year":"2018","unstructured":"Piening, B. D. et al. Integrative personal omics profiles during periods of weight gain and loss. Cell Syst. 6, 157-170.e158. https:\/\/doi.org\/10.1016\/j.cels.2017.12.013 (2018).","journal-title":"Cell Syst."},{"key":"47030_CR14","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1038\/s41467-017-02182-z","volume":"8","author":"J Carayol","year":"2017","unstructured":"Carayol, J. et al. Protein quantitative trait locus study in obesity during weight-loss identifies a leptin regulator. Nat. Commun. 8, 2084. https:\/\/doi.org\/10.1038\/s41467-017-02182-z (2017).","journal-title":"Nat. Commun."},{"key":"47030_CR15","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1074\/mcp.RA118.001288","volume":"18","author":"R Bruderer","year":"2019","unstructured":"Bruderer, R. et al. Analysis of 1508 plasma samples by capillary-flow data-independent acquisition profiles proteomics of weight loss and maintenance. Mol. Cell Proteom. 18, 1242\u20131254. https:\/\/doi.org\/10.1074\/mcp.RA118.001288 (2019).","journal-title":"Mol. Cell Proteom."},{"key":"47030_CR16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cels.2018.10.012","volume":"7","author":"NJ Wewer Albrechtsen","year":"2018","unstructured":"Wewer Albrechtsen, N. J. et al. Plasma proteome profiling reveals dynamics of inflammatory and lipid homeostasis markers after Roux-En-Y gastric bypass surgery. Cell Syst. 7, 601\u2013612. https:\/\/doi.org\/10.1016\/j.cels.2018.10.012 (2018).","journal-title":"Cell Syst."},{"key":"47030_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/oby.2008.428","volume":"17","author":"DM Culnan","year":"2009","unstructured":"Culnan, D. M., Cooney, R. N., Stanley, B. & Lynch, C. J. Apolipoprotein A-IV, a putative satiety\/antiatherogenic factor, rises after gastric bypass. Obesity (Silver Spring) 17, 46\u201352. https:\/\/doi.org\/10.1038\/oby.2008.428 (2009).","journal-title":"Obesity (Silver Spring)"},{"key":"47030_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/ATVBAHA.118.311928","volume":"39","author":"RV Shah","year":"2019","unstructured":"Shah, R. V. et al. Proteins altered by surgical weight loss highlight biomarkers of insulin resistance in the community. Arterioscler. Thromb. Vasc. Biol. 39, 107\u2013115. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311928 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"47030_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/oby.23303","volume":"30","author":"NA Yousri","year":"2022","unstructured":"Yousri, N. A. et al. Proteome-wide associations with short- and long-term weight loss and regain after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) 30, 129\u2013141. https:\/\/doi.org\/10.1002\/oby.23303 (2022).","journal-title":"Obesity (Silver Spring)"},{"key":"47030_CR20","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/s41366-021-00896-1","volume":"45","author":"LJ Goudswaard","year":"2021","unstructured":"Goudswaard, L. J. et al. Effects of adiposity on the human plasma proteome: Observational and Mendelian randomisation estimates. Int. J. Obes. (Lond.) 45, 2221\u20132229. https:\/\/doi.org\/10.1038\/s41366-021-00896-1 (2021).","journal-title":"Int. J. Obes. (Lond.)"},{"key":"47030_CR21","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41467-021-21542-4","volume":"12","author":"SB Zaghlool","year":"2021","unstructured":"Zaghlool, S. B. et al. Revealing the role of the human blood plasma proteome in obesity using genetic drivers. Nat. Commun. 12, 1279. https:\/\/doi.org\/10.1038\/s41467-021-21542-4 (2021).","journal-title":"Nat. Commun."},{"key":"47030_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658\u2013665. https:\/\/doi.org\/10.1002\/gepi.21758 (2013).","journal-title":"Genet. Epidemiol."},{"key":"47030_CR23","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor, D. A., Harbord, R. M., Sterne, J. A., Timpson, N. & Davey Smith, G. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat. Med. 27, 1133\u20131163. https:\/\/doi.org\/10.1002\/sim.3034 (2008).","journal-title":"Stat. Med."},{"key":"47030_CR24","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/ije\/dyt110","volume":"42","author":"G Freeman","year":"2013","unstructured":"Freeman, G., Cowling, B. J. & Schooling, C. M. Power and sample size calculations for Mendelian randomization studies using one genetic instrument. Int. J. Epidemiol. 42, 1157\u20131163. https:\/\/doi.org\/10.1093\/ije\/dyt110 (2013).","journal-title":"Int. J. Epidemiol."},{"key":"47030_CR25","doi-asserted-by":"publisher","unstructured":"Sun, B. B. et al. Genetic regulation of the human plasma proteome in 54,306 UK Biobank participants. bioRxiv, 2022.2006.2017.496443 (2022). https:\/\/doi.org\/10.1101\/2022.06.17.496443","DOI":"10.1101\/2022.06.17.496443"},{"key":"47030_CR26","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53, 1712\u20131721. https:\/\/doi.org\/10.1038\/s41588-021-00978-w (2021).","journal-title":"Nat. Genet."},{"key":"47030_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s0895-4356(98)00138-3","volume":"52","author":"WN Kernan","year":"1999","unstructured":"Kernan, W. N., Viscoli, C. M., Makuch, R. W., Brass, L. M. & Horwitz, R. I. Stratified randomization for clinical trials. J. Clin. Epidemiol. 52, 19\u201326. https:\/\/doi.org\/10.1016\/s0895-4356(98)00138-3 (1999).","journal-title":"J. Clin. Epidemiol."},{"key":"47030_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1575","volume":"353","author":"H McGuire","year":"2016","unstructured":"McGuire, H. et al. Management of type 2 diabetes in adults: summary of updated NICE guidance. BMJ 353, i1575. https:\/\/doi.org\/10.1136\/bmj.i1575 (2016).","journal-title":"BMJ"},{"key":"47030_CR29","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1007\/s00125-012-2496-2","volume":"55","author":"S Paul","year":"2012","unstructured":"Paul, S., Thomas, G., Majeed, A., Khunti, K. & Klein, K. Women develop type 2 diabetes at a higher body mass index than men. Diabetologia 55, 1556\u20131557. https:\/\/doi.org\/10.1007\/s00125-012-2496-2 (2012).","journal-title":"Diabetologia"},{"key":"47030_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001925","volume":"12","author":"IJ Douglas","year":"2015","unstructured":"Douglas, I. J., Bhaskaran, K., Batterham, R. L. & Smeeth, L. Bariatric surgery in the United Kingdom: A cohort study of weight loss and clinical outcomes in routine clinical care. PLoS Med 12, e1001925. https:\/\/doi.org\/10.1371\/journal.pmed.1001925 (2015).","journal-title":"PLoS Med"},{"key":"47030_CR31","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/oby.23746","volume":"31","author":"B. B. S. C","year":"2023","unstructured":"Group & B. B. S. C,. Roux-en-Y gastric bypass, gastric banding, or sleeve gastrectomy for severe obesity: Baseline data from the By-Band-Sleeve randomized controlled trial. Obesity (Silver Spring) 31, 1290\u20131299. https:\/\/doi.org\/10.1002\/oby.23746 (2023).","journal-title":"Obesity (Silver Spring)"},{"key":"47030_CR32","doi-asserted-by":"publisher","unstructured":"Haslam, D. E. et al. Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms. Proteomics, e2100170 (2022). https:\/\/doi.org\/10.1002\/pmic.202100170","DOI":"10.1002\/pmic.202100170"},{"key":"47030_CR33","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart, D. S. et al. DrugBank: A comprehensive resource for in silico drug discovery and exploration. Nucl. Acids Res. 34, D668-672. https:\/\/doi.org\/10.1093\/nar\/gkj067 (2006).","journal-title":"Nucl. Acids Res."},{"key":"47030_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aag1166","volume":"9","author":"C Finan","year":"2017","unstructured":"Finan, C. et al. The druggable genome and support for target identification and validation in drug development. Sci. Transl. Med. 9, 1. https:\/\/doi.org\/10.1126\/scitranslmed.aag1166 (2017).","journal-title":"Sci. Transl. Med."},{"key":"47030_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells10102798","volume":"10","author":"HA Fachim","year":"2021","unstructured":"Fachim, H. A. et al. Relationship between the plasma proteome and changes in inflammatory markers after bariatric surgery. Cells 10, 1. https:\/\/doi.org\/10.3390\/cells10102798 (2021).","journal-title":"Cells"},{"key":"47030_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096489","volume":"9","author":"M J\u00fcllig","year":"2014","unstructured":"J\u00fcllig, M. et al. Lower fetuin-A, retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes. PLoS One 9, e96489. https:\/\/doi.org\/10.1371\/journal.pone.0096489 (2014).","journal-title":"PLoS One"},{"key":"47030_CR37","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1177\/1535370214523894","volume":"239","author":"AA Alfadda","year":"2014","unstructured":"Alfadda, A. A. et al. A proteomic analysis of excreted and circulating proteins from obese patients following two different weight-loss strategies. Exp. Biol. Med. (Maywood) 239, 568\u2013580. https:\/\/doi.org\/10.1177\/1535370214523894 (2014).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"47030_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/dmrr.919","volume":"25","author":"SN Rajpathak","year":"2009","unstructured":"Rajpathak, S. N. et al. The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab. Res. Rev. 25, 3\u201312. https:\/\/doi.org\/10.1002\/dmrr.919 (2009).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"47030_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.molmet.2018.10.008","volume":"19","author":"NJ Haywood","year":"2019","unstructured":"Haywood, N. J., Slater, T. A., Matthews, C. J. & Wheatcroft, S. B. The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes. Mol. Metab. 19, 86\u201396. https:\/\/doi.org\/10.1016\/j.molmet.2018.10.008 (2019).","journal-title":"Mol. Metab."},{"key":"47030_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100248","volume":"2","author":"J Faramia","year":"2021","unstructured":"Faramia, J. et al. IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery. Cell Rep. Med. 2, 100248. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100248 (2021).","journal-title":"Cell Rep. Med."},{"key":"47030_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","volume":"16","author":"WP Arend","year":"1998","unstructured":"Arend, W. P., Malyak, M., Guthridge, C. J. & Gabay, C. Interleukin-1 receptor antagonist: Role in biology. Annu. Rev. Immunol. 16, 27\u201355. https:\/\/doi.org\/10.1146\/annurev.immunol.16.1.27 (1998).","journal-title":"Annu. Rev. Immunol."},{"key":"47030_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00365513.2011.626868","volume":"72","author":"HJ M\u00f8ller","year":"2012","unstructured":"M\u00f8ller, H. J. Soluble CD163. Scand. J. Clin. Lab. Invest. 72, 1\u201313. https:\/\/doi.org\/10.3109\/00365513.2011.626868 (2012).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"47030_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222815","volume":"14","author":"CH Lee","year":"2019","unstructured":"Lee, C. H. et al. Serum E-selectin concentration is associated with risk of metabolic syndrome in females. PLoS One 14, e0222815. https:\/\/doi.org\/10.1371\/journal.pone.0222815 (2019).","journal-title":"PLoS One"},{"key":"47030_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100437","volume":"2","author":"N Ghodsian","year":"2021","unstructured":"Ghodsian, N. et al. Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease. Cell Rep Med 2, 100437. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100437 (2021).","journal-title":"Cell Rep Med"},{"key":"47030_CR45","doi-asserted-by":"publisher","unstructured":"Ritchie, S. C. et al. Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases. bioRxiv, 2019.2012.2014.876474 (2021). https:\/\/doi.org\/10.1101\/2019.12.14.876474","DOI":"10.1101\/2019.12.14.876474"},{"key":"47030_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg, L. et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell Proteom. 13, 397\u2013406. https:\/\/doi.org\/10.1074\/mcp.M113.035600 (2014).","journal-title":"Mol. Cell Proteom."},{"key":"47030_CR47","doi-asserted-by":"publisher","unstructured":"Sethi, A., Raj, A., Wright, K. & Melamud, E. Plasma Proteomic Determinants of Common Causes of Mortality. PREPRINT (version 1) available at Research Square (2023). https:\/\/doi.org\/10.21203\/rs.3.rs-2626017\/v1","DOI":"10.21203\/rs.3.rs-2626017\/v1"},{"key":"47030_CR48","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.2337\/db19-1070","volume":"69","author":"V Gudmundsdottir","year":"2020","unstructured":"Gudmundsdottir, V. et al. Circulating protein signatures and causal candidates for type 2 diabetes. Diabetes 69, 1843\u20131853. https:\/\/doi.org\/10.2337\/db19-1070 (2020).","journal-title":"Diabetes"},{"key":"47030_CR49","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1021\/cr068287r","volume":"107","author":"HJ Issaq","year":"2007","unstructured":"Issaq, H. J., Xiao, Z. & Veenstra, T. D. Serum and plasma proteomics. Chem. Rev. 107, 3601\u20133620. https:\/\/doi.org\/10.1021\/cr068287r (2007).","journal-title":"Chem. Rev."},{"key":"47030_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik, L. et al. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol. Cell Proteom. 20, 100168. https:\/\/doi.org\/10.1016\/j.mcpro.2021.100168 (2021).","journal-title":"Mol. Cell Proteom."},{"key":"47030_CR51","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","volume":"391","author":"ME Lean","year":"2018","unstructured":"Lean, M. E. et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): An open-label, cluster-randomised trial. Lancet 391, 541\u2013551. https:\/\/doi.org\/10.1016\/S0140-6736(17)33102-1 (2018).","journal-title":"Lancet"},{"key":"47030_CR52","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.3399\/bjgp13X663073","volume":"63","author":"M Lean","year":"2013","unstructured":"Lean, M. et al. Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity. Br. J. Gen. Pract. 63, e115-124. https:\/\/doi.org\/10.3399\/bjgp13X663073 (2013).","journal-title":"Br. J. Gen. Pract."},{"key":"47030_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.49","volume":"3","author":"JC Rohloff","year":"2014","unstructured":"Rohloff, J. C. et al. Nucleic acid ligands with protein-like side chains: Modified aptamers and their use as diagnostic and therapeutic agents. Mol. Ther. Nucl. Acids 3, e201. https:\/\/doi.org\/10.1038\/mtna.2014.49 (2014).","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"47030_CR54","unstructured":"SomaLogic. SomaScan\u00ae v4 Data Standardization and File Specification Technical Note [White paper]. (2022). https:\/\/somalogic.com\/tech-notes\/."},{"key":"47030_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btac059","author":"DA Hughes","year":"2022","unstructured":"Hughes, D. A. et al. metaboprep: An R package for preanalysis data description and processing. Bioinformatics https:\/\/doi.org\/10.1093\/bioinformatics\/btac059 (2022).","journal-title":"Bioinformatics"},{"key":"47030_CR56","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/s0197-2456(02)00242-8","volume":"23","author":"NW Scott","year":"2002","unstructured":"Scott, N. W., McPherson, G. C., Ramsay, C. R. & Campbell, M. K. The method of minimization for allocation to clinical trials. A review. Control Clin. Trials 23, 662\u2013674. https:\/\/doi.org\/10.1016\/s0197-2456(02)00242-8 (2002).","journal-title":"Control Clin. Trials"},{"key":"47030_CR57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1745-6215-15-53","volume":"15","author":"CA Rogers","year":"2014","unstructured":"Rogers, C. A. et al. The By-Band study: Gastric bypass or adjustable gastric band surgery to treat morbid obesity: Study protocol for a multi-centre randomised controlled trial with an internal pilot phase. Trials 15, 53. https:\/\/doi.org\/10.1186\/1745-6215-15-53 (2014).","journal-title":"Trials"},{"key":"47030_CR58","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/ijo.2017.153","volume":"41","author":"S Paramasivan","year":"2017","unstructured":"Paramasivan, S. et al. Enabling recruitment success in bariatric surgical trials: pilot phase of the By-Band-Sleeve study. Int. J. Obes. (Lond.) 41, 1654\u20131661. https:\/\/doi.org\/10.1038\/ijo.2017.153 (2017).","journal-title":"Int. J. Obes. (Lond.)"},{"key":"47030_CR59","unstructured":"Olink Proteomics. PEA \u2013 a high-multiplex immunoassay technology with qPCR or NGS readout [White paper]. https:\/\/www.olink.com\/application\/pea-a-high-multiplex-immunoassay-technology-with-qpcr-or-ngs-readout-2\/ (2020)."},{"key":"47030_CR60","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","volume":"27","author":"L Yengo","year":"2018","unstructured":"Yengo, L. et al. Meta-analysis of genome-wide association studies for height and body mass index in \u223c700000 individuals of European ancestry. Hum Mol Genet 27, 3641\u20133649. https:\/\/doi.org\/10.1093\/hmg\/ddy271 (2018).","journal-title":"Hum Mol Genet"},{"key":"47030_CR61","doi-asserted-by":"publisher","first-page":"eabm5164","DOI":"10.1126\/sciadv.abm5164","volume":"8","author":"DH Katz","year":"2022","unstructured":"Katz, D. H. et al. Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods. Sci Adv 8, eabm5164. https:\/\/doi.org\/10.1126\/sciadv.abm5164 (2022).","journal-title":"Sci Adv"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47030-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T18:10:27Z","timestamp":1701281427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47030-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["47030"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-47030-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"assertion":[{"value":"11 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RT has received lecture honoraria from Eli Lilly, Nestle Health and Janssen. NS has received consulting and\/or speaker honoraria from Abbott Laboratories, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer, Roche Diagnostics, and Sanofi; and grant funding support paid to his University from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche Diagnostics outside the submitted work. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21077"}}